Chase Coleman - Tiger Global Management
Holding/activity history for  Novo Nordisk A S (NVO)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2024   Q3 | 1,269,000 | 0.64 | $119.07 | ||
2024   Q2 | 1,269,000 | 0.84 | $142.74 | ||
2024   Q1 | 1,269,000 | 0.89 | $128.40 | ||
2023   Q4 | 1,269,000 | 0.93 | $103.45 | ||
2023   Q3 | 1,269,000 | 0.85 | $90.94 | ||
2023   Q2 | 1,269,000 | 0.86 | Buy | 0.86 | $80.91 |